Peter P. Pfreundschuh
2014 - Immunomedics
In 2014, Peter P. Pfreundschuh earned a total compensation of $566.1K as Former VP Finance and Chief Financial Officer at Immunomedics.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Option Awards | $253,860 |
| Salary | $235,490 |
| Other | $1,781 |
| Total | $566,131 |
Pfreundschuh received $253.9K in option awards, accounting for 45% of the total pay in 2014.
Pfreundschuh also received $75K in non-equity incentive plan, $235.5K in salary and $1.8K in other compensation.
Rankings
In 2014, Peter P. Pfreundschuh's compensation ranked 9,873rd out of 13,032 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 24.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,873 out of 13,032 | 24th |
Division Manufacturing | 3,742 out of 4,965 | 25th |
Major group Chemicals And Allied Products | 1,285 out of 1,690 | 24th |
Industry group Drugs | 1,025 out of 1,369 | 25th |
Industry In Vitro and In Vivo Diagnostic Substances | 45 out of 72 | 38th |
Source: SEC filing on November 2, 2016.
Pfreundschuh's colleagues
We found two more compensation records of executives who worked with Peter P. Pfreundschuh at Immunomedics in 2014.
News
Korro Bio CEO David Lucchino's 2020 pay falls 29% to $5.2M
April 29, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
April 29, 2020
UroGen Pharma Ltd. CEO Ron Bentsur's 2018 pay jumps 202% to $6M
April 26, 2019